Fmr LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 54,026 shares of KALV stock, worth $594,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,026

Previous 50,907 6.13%

Holding current value

$594,286

Previous $603,000 5.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.35 - $12.49 $32,281 - $38,956	3,119 Added 6.13%	54,026 $636,000
Q1 2024 May 13, 2024	SELL	$11.07 - $16.04 $697 - $1,010	-63 Reduced 0.12%	50,907 $603,000
Q4 2023 Feb 13, 2024	SELL	$7.58 - $12.25 $49,997 - $80,801	-6,596 Reduced 11.46%	50,970 $624,000
Q3 2023 Nov 13, 2023	SELL	$8.95 - $11.35 $119,026 - $150,943	-13,299 Reduced 18.77%	57,566 $554,000
Q2 2023 Aug 11, 2023	SELL	$7.73 - $10.57 $231 - $317	-30 Reduced 0.04%	70,865 $637,000
Q1 2023 May 11, 2023	SELL	$6.3 - $8.39 $7.81 Million - $10.4 Million	-1,240,107 Reduced 94.59%	70,895 $557,000
Q4 2022 Feb 13, 2023	BUY	$4.2 - $14.24 $640,991 - $2.17 Million	152,617 Added 13.17%	1,311,002 $8.86 Million
Q3 2022 Nov 10, 2022	BUY	$9.85 - $16.83 $255,538 - $436,620	25,943 Added 2.29%	1,158,385 $16.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.16 - $15.1 $2.51 Million - $4.64 Million	307,092 Added 37.21%	1,132,442 $11.1 Million
Q1 2022 May 13, 2022	BUY	$11.2 - $16.97 $427,056 - $647,066	38,130 Added 4.84%	825,350 $12.2 Million
Q4 2021 Feb 14, 2022	SELL	$12.36 - $18.28 $2.15 Million - $3.18 Million	-173,741 Reduced 18.08%	787,220 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$17.11 - $24.49 $2.19 Million - $3.13 Million	-127,829 Reduced 11.74%	960,961 $16.8 Million
Q2 2021 Aug 13, 2021	BUY	$23.12 - $29.91 $25.2 Million - $32.6 Million	1,088,790 New	1,088,790 $26.1 Million

Others Institutions Holding KALV

# of Institutions

121

Shares Held

47.7M

Call Options Held

71.8K

Put Options Held

26.3K

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $271M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account